Healthcare | August 16, 2021
Apollo Hospitals PAT at Rs 489.28 cr. in Q1FY22
The hospital chain aggressively embarks on digitisation and is e-health ready
The hospital chain aggressively embarks on digitisation and is e-health ready
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
The company is eligible for 12 months exclusivity from launch
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
The company is doubling its chemistry research capacity that should commission by Q2'FY22
Essential medicines were made available to more than 150 countries around the world during the pandemic
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
Subscribe To Our Newsletter & Stay Updated
